In response to the health needs of the population, we capture information, analyze and produce the best medicines to generate well-being.
Committed to the development of new dosage forms and the creation or improvement of medical devices, we offer high-value competitive advantages in competitive and niche markets.
We have various lines of pharmaceutical products with the highest quality controls, which are classified as:
Line of GENERIC DRUGS:
We developed a quality alternative for the prescription of various drugs such as captopril, carbamazepine, lysine clonixinate, enalapril, among others.
BIOTECHNOLOGICAL PRODUCTS line:
They are products based on antibodies and therapeutic peptides, aimed at the treatment of ocular, inflammatory, neurodegenerative diseases, autoimmune disorders, infectious diseases and diabetes.
Silanes invests in infrastructure and technology, responding to the growing demand for products that respond to real health needs, achieving optimal levels of quality to obtain the maximum benefit from the medicines developed.